Literature DB >> 17945239

A novel method for production of lipid hydroperoxide- or oxysterol-rich low-density lipoprotein.

Andrew B Gerry1, Leanne Satchell, David S Leake.   

Abstract

LDL oxidation may be important in atherosclerosis. Extensive oxidation of LDL by copper induces increased uptake by macrophages, but results in decomposition of hydroperoxides, making it more difficult to investigate the effects of hydroperoxides in oxidised LDL on cell function. We describe here a simple method of oxidising LDL by dialysis against copper ions at 4 degrees C, which inhibits the decomposition of hydroperoxides, and allows the production of LDL rich in hydroperoxides (626+/-98 nmol/mg LDL protein) but low in oxysterols (3+/-1 nmol 7-ketocholesterol/mg LDL protein), whilst allowing sufficient modification (2.6+/-0.5 relative electrophoretic mobility) for rapid uptake by macrophages (5.49+/-0.75 microg (125)I-labelled hydroperoxide-rich LDL vs. 0.46+/-0.04 microg protein/mg cell protein in 18 h for native LDL). By dialysing under the same conditions, but at 37 degrees C, the hydroperoxides are decomposed extensively and the LDL becomes rich in oxysterols. This novel method of oxidising LDL with high yield to either a hydroperoxide- or oxysterol-rich form by simply altering the temperature of dialysis may provide a useful tool for determining the effects of these different oxidation products on cell function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945239     DOI: 10.1016/j.atherosclerosis.2007.08.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  7-ketocholesterol is not cytotoxic to U937 cells when incorporated into acetylated low density lipoprotein.

Authors:  Lucy D Rutherford; Steven P Gieseg
Journal:  Lipids       Date:  2011-11-29       Impact factor: 1.880

2.  Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.

Authors:  Simbarashe Magwenzi; Casey Woodward; Katie S Wraith; Ahmed Aburima; Zaher Raslan; Huw Jones; Catriona McNeil; Stephen Wheatcroft; Nadira Yuldasheva; Maria Febbriao; Mark Kearney; Khalid M Naseem
Journal:  Blood       Date:  2015-02-20       Impact factor: 22.113

3.  Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.

Authors:  Katie S Wraith; Simbarashe Magwenzi; Ahmed Aburima; Yichuan Wen; David Leake; Khalid M Naseem
Journal:  Blood       Date:  2013-05-22       Impact factor: 22.113

4.  Oxidation of low-density lipoprotein by iron at lysosomal pH: implications for atherosclerosis.

Authors:  Leanne Satchell; David S Leake
Journal:  Biochemistry       Date:  2012-04-25       Impact factor: 3.162

5.  The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling.

Authors:  Charys Palmer; Francesco Peri; Frank Neumann; Feroz Ahmad; David S Leake; Grisha Pirianov
Journal:  Innate Immun       Date:  2018-09-12       Impact factor: 2.680

6.  Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.

Authors:  Yichuan Wen; Feroz Ahmad; Zahra Mohri; Peter D Weinberg; David S Leake
Journal:  Atherosclerosis       Date:  2019-09-26       Impact factor: 5.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.